Literature DB >> 18557739

Increase of integrin-linked kinase activity in cultured podocytes upon stimulation with plasma from patients with recurrent FSGS.

M Hattori1, Y Akioka, H Chikamoto, N Kobayashi, K Tsuchiya, M Shimizu, S Kagami, H Tsukaguchi.   

Abstract

Recurrent focal segmental glomerulosclerosis (FSGS) is a major challenge in the field of transplantation. Integrin-linked kinase (ILK) has emerged as a key mediator of podocyte-glomerular basement membrane (GBM) interactions. To clarify the involvement of plasma factors in FSGS recurrence, we examined the effects of plasma from FSGS patients with or without posttransplant recurrence on cultured podocytes, focusing particularly on ILK activity. Podocytes from a conditionally immortalized mouse podocyte cell line were treated with plasma from 11 FSGS patients, and ILK activity was determined using an immune complex kinase assay. Treatment with plasma from three patients with recurrence induced an increase in ILK activity. In contrast, no increase in ILK activity was observed in cultured podocytes treated with plasma from the remaining three patients with recurrence and five patients without recurrence. Cultured podocytes treated with plasma that induced ILK activity showed alterations of focal contact and detachment from the laminin matrix. In conclusion, this preliminary study provides experimental evidence suggesting the possible presence of circulating toxic factors in the plasma of some patients with recurrent FSGS, which induce an increase in podocyte ILK activity that may lead to the detachment of podocytes from the GBM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18557739     DOI: 10.1111/j.1600-6143.2008.02287.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  10 in total

1.  Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.

Authors:  Alessia Fornoni; Junichiro Sageshima; Changli Wei; Sandra Merscher-Gomez; Robier Aguillon-Prada; Alexandra N Jauregui; Jing Li; Adela Mattiazzi; Gaetano Ciancio; Linda Chen; Gaston Zilleruelo; Carolyn Abitbol; Jayanthi Chandar; Wacheree Seeherunvong; Camillo Ricordi; Masami Ikehata; Maria Pia Rastaldi; Jochen Reiser; George W Burke
Journal:  Sci Transl Med       Date:  2011-06-01       Impact factor: 17.956

Review 2.  The integrin adhesome: from genes and proteins to human disease.

Authors:  Sabina E Winograd-Katz; Reinhard Fässler; Benjamin Geiger; Kyle R Legate
Journal:  Nat Rev Mol Cell Biol       Date:  2014-04       Impact factor: 94.444

3.  Recurrent focal segmental glomerulosclerosis after kidney transplantation.

Authors:  Rebecca Trachtman; Simranjeet S Sran; Howard Trachtman
Journal:  Pediatr Nephrol       Date:  2015-02-19       Impact factor: 3.714

4.  Plasma from a case of recurrent idiopathic FSGS perturbs non-muscle myosin IIA (MYH9 protein) in human podocytes.

Authors:  Sima Babayeva; Michelle Miller; Yulia Zilber; Reyhan El Kares; Chantale Bernard; Martin Bitzan; Paul Goodyer; Elena Torban
Journal:  Pediatr Nephrol       Date:  2011-03-06       Impact factor: 3.714

Review 5.  Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis--a review.

Authors:  M M Löwik; P J Groenen; E N Levtchenko; L A Monnens; L P van den Heuvel
Journal:  Eur J Pediatr       Date:  2009-06-27       Impact factor: 3.183

6.  Final adult height in kidney recipients who underwent highly successful transplantation as children: a single-center experience.

Authors:  Hiroshi Fujii; Hiroko Chikamoto; Yuko Akioka; Motoshi Hattori
Journal:  Clin Exp Nephrol       Date:  2013-07-18       Impact factor: 2.801

7.  Amount and selectivity of proteinuria may predict the treatment response in post-transplant recurrence of focal segmental glomerulosclerosis: a single-center retrospective study.

Authors:  Hideki Ban; Kenichiro Miura; Naoto Kaneko; Yoko Shirai; Tomoo Yabuuchi; Kiyonobu Ishizuka; Hiroko Chikamoto; Yuko Akioka; Satoru Shimizu; Hideki Ishida; Kazunari Tanabe; Motoshi Hattori
Journal:  Pediatr Nephrol       Date:  2021-02-04       Impact factor: 3.714

8.  Degree of foot process effacement in patients with genetic focal segmental glomerulosclerosis: a single-center analysis and review of the literature.

Authors:  Kiyonobu Ishizuka; Kenichiro Miura; Taeko Hashimoto; Naoto Kaneko; Yutaka Harita; Tomoo Yabuuchi; Masataka Hisano; Shuichiro Fujinaga; Tae Omori; Yutaka Yamaguchi; Motoshi Hattori
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

Review 9.  Application of next-generation sequencing technology to diagnosis and treatment of focal segmental glomerulosclerosis.

Authors:  Yutaka Harita
Journal:  Clin Exp Nephrol       Date:  2017-07-27       Impact factor: 2.801

Review 10.  Disease Recurrence-The Sword of Damocles in Kidney Transplantation for Primary Focal Segmental Glomerulosclerosis.

Authors:  Katrin Kienzl-Wagner; Siegfried Waldegger; Stefan Schneeberger
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.